Article thumbnail

Heme Oxygenase-1 Induction and Organic Nitrate Therapy: Beneficial Effects on Endothelial Dysfunction, Nitrate Tolerance, and Vascular Oxidative Stress

By Andreas Daiber, Matthias Oelze, Philip Wenzel, Franziska Bollmann, Andrea Pautz and Hartmut Kleinert

Abstract

Organic nitrates are a group of very effective anti-ischemic drugs. They are used for the treatment of patients with stable angina, acute myocardial infarction, and chronic congestive heart failure. A major therapeutic limitation inherent to organic nitrates is the development of tolerance, which occurs during chronic treatment with these agents, and this phenomenon is largely based on induction of oxidative stress with subsequent endothelial dysfunction. We therefore speculated that induction of heme oxygenase-1 (HO-1) could be an efficient strategy to overcome nitrate tolerance and the associated side effects. Indeed, we found that hemin cotreatment prevented the development of nitrate tolerance and vascular oxidative stress in response to chronic nitroglycerin therapy. Vice versa, pentaerithrityl tetranitrate (PETN), a nitrate that was previously reported to be devoid of adverse side effects, displayed tolerance and oxidative stress when the HO-1 pathway was blocked pharmacologically or genetically by using HO-1+/– mice. Recently, we identified activation of Nrf2 and HuR as a principle mechanism of HO-1 induction by PETN. With the present paper, we present and discuss our recent and previous findings on the role of HO-1 for the prevention of nitroglycerin-induced nitrate tolerance and for the beneficial effects of PETN therapy

Topics: Review Article
Publisher: Hindawi Publishing Corporation
OAI identifier: oai:pubmedcentral.nih.gov:3312327
Provided by: PubMed Central

Suggested articles

Citations

  1. (2003). 5-HT1B/1D serotonin receptor agonist attenuates nitroglycerin-evoked nitric oxide synthase expression in trigeminal pathway,”
  2. (2007). A role for brain cyclooxygenase-2 and prostaglandin-E2 in migraine: effects of nitroglycerin,”
  3. (2001). A.Hacker,S.Muller,W.Meyer,andG.Kojda,“Thenitricoxide donor pentaerythritol tetranitrate can preserve endothelial function in established atherosclerosis,”
  4. (2002). Adverse effects of nitroglycerin treatment on endothelial function, vascular nitrotyrosine levels and cGMP-dependent protein kinase activity in hyperlipidemic Watanabe rabbits,”
  5. (2009). Analysis of nitric oxide-stabilized mRNAs in human fibroblasts reveals HuR-dependent heme oxygenase 1 upregulation,”
  6. (2004). and protein kinase C in the development of tolerance to nitroglycerin,”
  7. (2003). B.J.Buckley,Z.M.Marshall,andA.R.Whorton,“Nitricoxide stimulates Nrf2 nuclear translocation in vascular endothelium,”
  8. (1973). B.JakschikandP.Needleman,“Sulfhydrylreactivityoforganic nitrates: biochemical basis for inhibition of glyceraldehyde p dehydrogenase and monoamine oxidase,”
  9. (2006). Cardiac genomic response following preconditioning stimulus,”
  10. (2002). cDNA microarray analysis of vascular gene expression after nitric oxide donor infusions in rats: implications for nitrate tolerance mechanisms,”
  11. (2004). Central role of mitochondrial aldehyde dehydrogenase and reactive oxygen species in nitroglycerin tolerance and cross-tolerance,”
  12. (2010). Characterization of the antioxidant properties of pentaerithrityl tetranitrate (PETN)-induction of the intrinsic antioxidative system heme
  13. (2003). Comparison of the effects of pentaerythritol tetranitrate and nitroglycerin on endothelium-dependent vasorelaxation in male volunteers,”
  14. (2006). Complex I dysfunction and tolerance to nitroglycerin: an approach based on mitochondrial-targeted antioxidants,”
  15. (2010). Conversion of biliverdin to bilirubin by biliverdin reductase contributes to endothelial cell protection by heme oxygenase-1-evidence for direct and indirect antioxidant actions of bilirubin,”
  16. (2005). cytokines, and its role in disease,”
  17. (2010). Di Stolfo et al., “Tolerance to nitroglycerin-induced preconditioning of the endothelium: a h umaninvi v ostud y ,
  18. (2007). Differential effects of organicnitratesonendothelialprogenitorcellsaredetermined by oxidative stress,”
  19. (2001). Differential effects of pentaerythritol tetranitrate and nitroglycerin on the development of tolerance and evidence of lipid peroxidation: a human in vivo study,”
  20. (2003). Does nitric oxide mediate the vasodilator activity of nitroglycerin?”
  21. (2009). Effects of nitroglycerin or pentaerithrityl tetranitrate treatment on the gene expression in rat hearts: evidence for cardiotoxic and cardioprotective effects,”
  22. (1966). Effects of organic nitrates on mitochondrial respiration and swelling: possible correlations with the mechanism of pharmacologic action,”
  23. (2005). Effects of the long-term administration of nicorandil on vascular endothelial function and the progression of arteriosclerosis,”
  24. (2007). Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function
  25. (2010). Evidence against tetrahydrobiopterin depletion of vascular tissue exposed to nitric oxide/superoxide or nitroglycerin,”
  26. (1997). Evidence for a role of oxygen derived free radicals and protein kinase C in nitrate tolerance,” J o u r n a lo fM o l e c u l a rM e d i c i n e ,
  27. (1995). Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance,”
  28. (2005). Explaining the phenomenon of nitrate tolerance,”
  29. (2007). Expression and protective role of heme oxygenase-1 in delayed myocardial preconditioning,”
  30. (2008). First evidence for a crosstalk between mitochondrial and NADPH oxidasederived reactive oxygen species in nitroglycerin-triggered vascular dysfunction,” Antioxidants and Redox Signaling,
  31. (2003). Fluvastatin attenuates nitrate tolerance in patients with ischemic heart disease complicating hypercholesterolemia,”
  32. (2001). Folic acid prevents nitroglycerin-induced nitric oxide synthase dysfunction and nitrate tolerance: a human in vivo study,”
  33. (2002). Functional and biochemical analysis of endothelial (Dys)function and NO/cGMPsignalinginhumanbloodvesselswithandwithout nitroglycerin pretreatment,”
  34. (2010). Heme oxygenase-1 deficiency leads to alteration of soluble guanylate cyclase redox regulation,”
  35. (2008). Heme oxygenase-1 promotes neovascularization in ischemic heart by coinduction of VEGF and SDF-1,”
  36. (2007). Heme oxygenase-1: a novel key player in the development of tolerance in response to organic nitrates,”
  37. (2002). Heme oxygenase1 induction may explain the antioxidant profile of pentaerythrityl trinitrate,”
  38. (2005). Heterozygous deficiency of manganese superoxide dismutase in mice (Mn-SOD+/-): a novel approach to assess the role of oxidative stress for the development of nitrate tolerance,”
  39. (2006). HO-1 is located in liver mitochondria and modulates mitochondrial heme content and metabolism,”
  40. (2007). How many transcription factors does it take to turn on the heme oxygenase-1 gene?”
  41. (2005). Hydralazine is a powerful inhibitor of peroxynitrite formation as a possible explanation for its beneficial effects on prognosis in patients with congestive heart failure,”
  42. Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase: a new action for an old drug,”
  43. (2002). Identification of the enzymatic mechanism of nitroglycerin bioactivation,”
  44. (2007). Increased superoxide production in nitrate tolerance is associated with NAD(P)H oxidase and aldehyde dehydrogenase 2 downregulation,”
  45. (2011). Induction of vascular GTP-cyclohydrolase i and endogenous tetrahydrobiopterin synthesis protect against inflammationinduced endothelial dysfunction in human atherosclerosis,”
  46. (2007). Microarray-based gene expression profiling to elucidate cellular responses to nitric oxidea review from an analytical and biomedical point of view,”
  47. (2006). Mitochondrial oxidative stress and nitrate tolerance—comparison of nitroglycerin and pentaerithrityl tetranitrate in Mn-SOD+/-
  48. (1995). NADPH-diaphorase activity and Fos expression in brain nuclei following nitroglycerin administration,”
  49. (2007). Neuroprotective effect of nitroglycerin in a rodent model of ischemic stroke:
  50. (2008). New insights into bioactivation of organic nitrates, nitrate tolerance and cross-tolerance,”
  51. (2011). Nitrate therapy: new aspects concerning molecular action and tolerance,”
  52. (2005). Nitrate tolerance aggravates postischemic myocardial apoptosis and impairs cardiac functional recovery after ischemia,”
  53. (2009). Nitrate tolerance as a model of vascular dysfunction: roles for mitochondrial aldehyde dehydrogenase and mitochondrial oxidative stress,”
  54. (2008). Nitrate-induced toxicity and preconditioning. A rationale for reconsidering the use of these drugs,”
  55. (2005). Nitric oxide and gene expression,”
  56. (2001). Nitric oxide and the regulation of gene expression,”
  57. (2007). Nitric oxide stimulates heme oxygenase-1 gene transcription via the Nrf2/ARE complex to promote vascular smooth muscle cell survival,”
  58. (2006). Nitric oxide-induced down-regulation of β-catenin in colon cancer cells by a proteasome-independent specific pathway,”
  59. (2004). Nitric oxide-induced transcriptional up-regulation of protective genes by Nrf2 via the antioxidant response element counteracts apoptosis of neuroblastoma cells,”
  60. (2000). Nitric oxide-inducible expression ofhemeoxygenase-1 inhumancells. Translation-independent stabilization of the mRNA and evidence for direct action of nitric oxide,”
  61. (2006). Nitroglycerin attenuates human endothelial progenitor cell differentiation, function, and survival,”
  62. (2011). Nitroglycerin-induced endothelial dysfunction and tolerance involve adverse phosphorylation and S-glutathionylation of endothelial nitric oxide synthase: beneficial effects of therapy with the AT1 receptor blocker telmisartan,”
  63. (2009). Non-hemodynamic effects of organic nitrates and the distinctive characteristics of pentaerithrityl tetranitrate,”
  64. (2010). Organic nitrates and nitrate tolerance—state of the art and future developments,”
  65. (2003). Oxidative stress and cardiovascular injury: part II: animal and human studies,”
  66. (2004). Oxidative stress and mitochondrial aldehyde dehydrogenase activity: a comparison of pentaerythritol tetranitrate with other organic nitrates,”
  67. (2006). Oxidativer Stress, Redoxregulation und NO-Bioverf¨ ugbarkeit—Experimentelle und Klinische Aspekte, Steinkopff Verlag
  68. (2010). Pentaerythritol tetranitrate improves angiotensin II-induced vascular dysfunction via induction of heme
  69. (2007). Pentaerythrityl tetranitrate and nitroglycerin, but not isosorbide mononitrate, prevent endothelial dysfunction induced by ischemia and reperfusion,”
  70. (2008). Pharmacological and clinical aspects of heme oxygenase,”
  71. (2009). Pharmacological induction of vascular extracellular superoxide dismutase expressioninvivo,”JournalofCellularandMolecularMedicine,
  72. (2003). Prevention of nitrate tolerance by long-term treatment with statins,”
  73. (2007). Proteasome-dependent degradation of guanosine 5 -triphosphate cyclohydrolase I causes tetrahydrobiopterin defi-ciency in diabetes mellitus,”
  74. (2003). Regulation of gene expression by cyclic
  75. (1997). Regulation of heme oxygenase-1 gene expression in vascular smooth muscle cells by nitric oxide,”
  76. (2011). Regulation of heme oxygenase-1 protein expression by miR-377 in combination with miR-217,”
  77. (2007). Regulation of heme oxygenase1 mRNA deadenylation and turnover in NIH3T3 cells by nitrosative or alkylation stress,”
  78. (2003). Role for peroxynitrite in the inhibition of prostacyclin synthase in nitrate tolerance,”
  79. (2007). Role of reduced lipoic acid in the redox regulation of mitochondrial aldehyde dehydrogenase (ALDH-2) activity: implications for mitochondrial oxidative stress and nitrate tolerance,”
  80. (2010). Simvastatin-dependent up-regulation of heme oxygenase-1 via mRNA stabilization in human endothelial cells,”
  81. (2007). Statins attenuate ischemia-reperfusion injury by inducing heme oxygenase-1 in infiltrating macrophages,”
  82. (2011). Stolfo et al., “Coadministration of atorvastatin prevents nitroglycerin-induced endothelial dysfunction and nitrate tolerance in healthy humans,”
  83. (2007). T h o m a s ,J .M .D i F a b i o ,T .G o r i ,a n dJ .D .P a r k e r , “Once daily therapy with isosorbide-5-mononitrate causes endothelialdysfunctioninhumans.Evidenceofafree-radicalmediated mechanism,”
  84. (2006). T.Gori,M.Lisi,andS.Forconi,“Ischemiaandreperfusion:the endothelialperspective.Aradicalview,”ClinicalHemorheology and Microcirculation,
  85. (2003). Tetrahydrobiopterindependent preservation of nitric oxide-mediated endothelial function in diabetes by targeted transgenic GTPcyclohydrolase I overexpression,”
  86. (1999). The antioxidant defense protein ferritin is a novel and specific target for pentaerithrityl tetranitrate in endothelial cells,”
  87. (2004). The antioxidant defense protein heme oxygenase 1 is a novel target for statins
  88. (2007). The CO/HO system reverses inhibition of mitochondrial biogenesis and prevents murine doxorubicin cardiomyopathy,”
  89. (2007). The heme catabolic pathway and its protective effects on oxidative stress-mediated diseases,”
  90. (2011). Translocation of heme oxygenase-1 to mitochondria is a novel cytoprotective mechanism against non-steroidal anti-inflammatory drug-induced mitochondrial oxidative stress, apoptosis, and gastric mucosal injury,”
  91. (2008). Tsujioka et al., “Effect of pioglitazone on nitroglycerin-induced impairment of nitric oxide bioavailability by a catheter-type nitric oxide sensor,”
  92. (1995). u n z e l ,A .G i a i d ,S .K u r z ,D .J .S t e w a rt ,a n dD .G .H a rri s o n , “Evidence for a role of endothelin 1 and protein kinase C in nitroglycerin tolerance,”
  93. (2011). Vascular dysfunction in experimental diabetes is improved by pentaerithrityl tetranitrate but not isosorbide-5-mononitrate therapy,”
  94. (1999). Vascular peroxynitrite formation during organic nitrate tolerance,”

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.